UNSPSC 51333601: Risperidone

This classification denotes an antipsychotic agent with the molecular formula C23H27FN4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L6UH7ZF8HC, chemically known as 4h-pyrido(1,2-a)pyrimidin-4-one, 6,7,8,9-tetrahydro-3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-2-methyl- but generally known as risperidone, which bears US NIH Compound Identifier 5073. European Medicines Agency schedules Risperidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10335MIG.

UNSPSC 51333601 Risperidone is a Commodity code that does not reflect the actual work being solicited under it in recent state and local procurement activity. The single recent opportunity in the data set—Seminole County, Florida's IFB60459723LAS, posted June 30, 2026—solicits naloxone and drug deactivation systems, not risperidone. This mismatch suggests either a coding error in the source database or that the code is not actively used for pharmaceutical procurement at the state and local level. The Seminole County IFB requests 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, and vendors must include all shipping and delivery costs in their bids.

The code shows minimal recent activity traceable to risperidone procurement. Absent additional recent opportunities correctly coded to this Commodity, no pattern of issuing bodies, geographic spread, or representative acquisitions can be established. Business development professionals should verify whether risperidone procurement activity at state and local levels uses a different UNSPSC code or falls under a higher-tier pharmaceutical family code, and treat the current code as dormant for practical pursuit purposes.